Aortic Thrombus and Embolism
Aortic Thrombus and Embolism is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 6.7k research works in it since 1950. 10.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the association between aortic atherosclerosis and various embolic events, including stroke, renal disease, and peripheral arterial embolism. It explores the diagnosis, treatment, and management of cholesterol embolization syndrome, atheroembolic renal disease, and mobile thrombi in the thoracic aorta. The role of anticoagulation therapy and transesophageal echocardiography in assessing aortic plaque morphology and predicting embolic risk is also discussed.
- Aortic Atherosclerosis
- Cholesterol Embolization Syndrome
- Atheroembolic Renal Disease
- Thoracic Aorta Plaque
- Ischemic Stroke
- Mobile Aortic Thrombus
- Cerebrovascular Events
- Atheromatous Plaques
- Transesophageal Echocardiography
- Anticoagulation Therapy
- Research works
- 6.7k fractional, since 1950
- In the world top 10%
- 708 per year above
- Top-10% rate
- 10.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +26% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Aortic Thrombus and Embolism research?
By volume, the United States and China publish the most (284 and 143 works in 2022–2025).
By volume, 2022–2025
- 1 United States 284 works
- 2 China 143 works
- 3 Japan 129 works
- 4 Germany 45 works
- 5 Italy 45 works
- 6 France 40 works
- 7 Spain 38 works
- 8 India 37 works
- 9 United Kingdom 34 works
- 10 Australia 21 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Aortic Thrombus and Embolism research?
By volume in 2022–2025, Nihon University publishes the most Aortic Thrombus and Embolism research, followed by Capital Medical University and Cleveland Clinic.
By volume, 2022–2025
- 1 Nihon UniversityJapan 6 works
- 2 Capital Medical UniversityChina 5 works
- 3 Cleveland ClinicUnited States 5 works
- 4 Mayo Clinic in ArizonaUnited States 5 works
- 5 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 5 works
- 6 National Cerebral and Cardiovascular CenterJapan 5 works
- 7 Kashiwa Municipal HospitalJapan 4 works
- 8 University of WashingtonUnited States 4 works
- 9 Yale UniversityUnited States 4 works
- 10 Ludwig-Maximilians-Universität MünchenGermany 3 works
Who are the leading researchers in Aortic Thrombus and Embolism?
The most-cited researchers publishing on Aortic Thrombus and Embolism include Valentı́n Fuster and Philippe Gabríel Steg.
- 1 Valentı́n Fuster United States 5.4k citations
- 2 Philippe Gabríel Steg France 2.8k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Aortic Thrombus and Embolism research done?
The largest centres of Aortic Thrombus and Embolism research in 2022–2025 are Beijing (China), Tokyo (Japan), Osaka (Japan) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Tokyo.
Largest cities, 2022–2025
Where it is the local speciality
- TokyoJP · 26.0 works3.0×
Location quotient: how much more of its research is in Aortic Thrombus and Embolism than the world average.
Is Aortic Thrombus and Embolism research growing?
Output in 2018–2022 was 26% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Aortic Thrombus and Embolism.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.